Calvin Scott Recalls Phentermine Capsules Due to Stability Study Deviations
Calvin Scott & Company is recalling specific lots of Phentermine 30 mg capsules because they were repackaged without supporting stability studies.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a moderate severity score under the rubric for minor labeling or process errors without reported illness.
Plain-English summary
Calvin Scott & Company, Inc. is voluntarily recalling specific lots of Phentermine 30 mg capsules. The recall was initiated due to Current Good Manufacturing Practice (cGMP) deviations where the drug products were repackaged into pouches without supporting stability studies.
The affected product is identified by NDC 00527-0597-10 and includes Lot numbers CS19309 and CS20098, with an expiration date of 12/21. The products were distributed to 12 physician consignees located in California, Idaho, Illinois, Oklahoma, and Rhode Island.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or pharmacist for guidance on replacement or disposal.
The recalled product
- Product
- Phentermine, 30 mg capsules, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-0597-10
- Manufacturer
- Calvin Scott & Company, Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: CS19309
- CS20098
- Exp 12/21
Distribution
Part of a larger recall action
This product is one of 3 recalled by Calvin Scott & Company, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Calvin Scott & Company, Inc.
See all →- SevereBenzonatate 100mg Capsules Label Mix-up — Wrong Medication in Bottles
FDA (Drugs) · 2022-06-01
- ModerateBenzphetamine tablets recalled due to label mix-up with Benzonatate
FDA (Drugs) · 2022-06-01
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Missing Stability Studies
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Stability Deviations
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Topiramate 25mg Tablets Due to Packaging Defect
FDA (Drugs) · 2020-08-26